ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$3.03
-0.73 (-19.41%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +20.5% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $3.03
Current
$3.03
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
-20.8%
Low target
Base Case
$3.65
+20.5%
Avg target
Bull Case
$4.80
+58.4%
High target
Risk/Reward
2.8x
Favorable
Price in Context
Target vs 52W High
$3.65
-97.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%